| Li, Xuejun |
NCT03087032: Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) |
|
|
| Recruiting | 4 | 164 | RoW | Liraglutide, Victozaa, Liraglutid, Liroglutide, Liraglutidum, Liraglutide Acetate, insulin glargine, Lantus | The First Affiliated Hospital of Xiamen University | Type 2 Diabetes Patients, Overweight and Obesity, Hyperglycaemia (Diabetic) | 01/25 | 02/25 | | |
| Liu, Changqin |
NCT03087032: Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) |
|
|
| Recruiting | 4 | 164 | RoW | Liraglutide, Victozaa, Liraglutid, Liroglutide, Liraglutidum, Liraglutide Acetate, insulin glargine, Lantus | The First Affiliated Hospital of Xiamen University | Type 2 Diabetes Patients, Overweight and Obesity, Hyperglycaemia (Diabetic) | 01/25 | 02/25 | | |
NCT06842524: Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome |
|
|
| Recruiting | 2 | 150 | RoW | Dihydroartemisinin, Placebo | Shanghai Zhongshan Hospital | Polycystic Ovary Syndrome (PCOS) | 09/26 | 12/26 | | |
TRF-PCOS, NCT03792282: Time-Restricted Feeding(TRF) on Overweight/Obese Women with Polycystic Ovarian Syndrome (PCOS) |
|
|
| Completed | N/A | 93 | RoW | Time Restricted Feeding, Usual care | The First Affiliated Hospital of Xiamen University | Polycystic Ovary Syndrome (PCOS), Overweight and Obesity | 06/23 | 07/23 | | |
| Recruiting | N/A | 140 | RoW | Time Restricted Feeding(TRF), Reduced Calorie Diet (RCD) | The First Affiliated Hospital of Xiamen University | Time-Restricted Feeding, Impaired Glucose Regulation, Overweight/Obese | 12/23 | 01/24 | | |
| Recruiting | N/A | 330 | RoW | regular treatment | The First Affiliated Hospital of Xiamen University | Diabetic Complications and Obstructive Sleep Apnea | 12/23 | 01/24 | | |
